BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1977110)

  • 21. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
    Bordi F; Meller E
    Brain Res; 1989 Dec; 504(2):276-83. PubMed ID: 2574622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic D1-receptor blockade: effects on D2-receptor agonist-induced yawning in rats.
    Hietala J; Lappalainen J; Syvälahti E
    J Pharm Pharmacol; 1991 Apr; 43(4):278-9. PubMed ID: 1676742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.
    Löschmann PA; Smith LA; Lange KW; Jaehnig P; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1991; 105(3):303-9. PubMed ID: 1686813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that dopamine in the nucleus accumbens is involved in the ability of rats to switch to cue-directed behaviours.
    van den Bos R; Charria Ortiz GA; Bergmans AC; Cools AR
    Behav Brain Res; 1991 Jan; 42(1):107-14. PubMed ID: 1827586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats.
    Arnt J; Hyttel J; Meier E
    Eur J Pharmacol; 1988 Oct; 155(1-2):37-47. PubMed ID: 2907491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G; Arnt J; Hyttel J
    Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.
    Kistrup K; Gerlach J
    Pharmacol Toxicol; 1987 Sep; 61(3):157-61. PubMed ID: 2891133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutant.
    Fitzgerald LW; Miller KJ; Ratty AK; Glick SD; Teitler M; Gross KW
    Brain Res; 1992 May; 580(1-2):18-26. PubMed ID: 1354555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H; Gerlach J; Mørkeberg F
    Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors.
    Meller E; Bordi F; Bohmaker K
    Life Sci; 1989; 44(15):1019-26. PubMed ID: 2564615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of adrenalectomy on responses mediated by dopamine D-1 and D-2 receptors.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1989 Mar; 162(2):237-44. PubMed ID: 2566498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between dopamine D1 and D2 receptors in the model of thyrotropin-releasing hormone (TRH)-induced behaviour in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Eur J Pharmacol; 1991 Aug; 201(1):11-6. PubMed ID: 1686587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL; Crocker AD
    Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.
    Asin KE; Bednarz LM
    Neurosci Lett; 1990 Jun; 113(3):286-91. PubMed ID: 2143274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
    Bradshaw CM; Sheridan RD; Szabadi E
    Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.